View in EDS PDF Full Text

High CYP2C19 phenotypic variability in gastrointestinal cancer patients.

Saved in:
Bibliographic Details
Title: High CYP2C19 phenotypic variability in gastrointestinal cancer patients.
Authors: Burns KE; Department of Molecular Medicine and Pathology, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. k.burns@auckland.ac.nz., Lo WY; Department of Molecular Medicine and Pathology, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand., Findlay MP; Discipline of Oncology, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Cancer Trials New Zealand, University of Auckland, Auckland, New Zealand., Sharples K; Cancer Trials New Zealand, University of Auckland, Auckland, New Zealand.; Department of Preventive and Social Medicine, University of Otago, PO Box 56, Dunedin, 9054, New Zealand., Laking G; Auckland City Hospital, Private Bag 92024, Auckland, 1142, New Zealand., Helsby NA; Department of Molecular Medicine and Pathology, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.
Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2016 Jan; Vol. 77 (1), pp. 195-204. Date of Electronic Publication: 2015 Nov 27.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26614509
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: High CYP2C19 phenotypic variability in gastrointestinal cancer patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Burns+KE%22">Burns KE</searchLink>; Department of Molecular Medicine and Pathology, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. k.burns@auckland.ac.nz.<br /><searchLink fieldCode="AU" term="%22Lo+WY%22">Lo WY</searchLink>; Department of Molecular Medicine and Pathology, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.<br /><searchLink fieldCode="AU" term="%22Findlay+MP%22">Findlay MP</searchLink>; Discipline of Oncology, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Cancer Trials New Zealand, University of Auckland, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Sharples+K%22">Sharples K</searchLink>; Cancer Trials New Zealand, University of Auckland, Auckland, New Zealand.; Department of Preventive and Social Medicine, University of Otago, PO Box 56, Dunedin, 9054, New Zealand.<br /><searchLink fieldCode="AU" term="%22Laking+G%22">Laking G</searchLink>; Auckland City Hospital, Private Bag 92024, Auckland, 1142, New Zealand.<br /><searchLink fieldCode="AU" term="%22Helsby+NA%22">Helsby NA</searchLink>; Department of Molecular Medicine and Pathology, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227806519%22">Cancer chemotherapy and pharmacology</searchLink> [Cancer Chemother Pharmacol] 2016 Jan; Vol. 77 (1), pp. 195-204. <i>Date of Electronic Publication: </i>2015 Nov 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7806519 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0843 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203445704%22">03445704 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Chemother Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26614509
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00280-015-2923-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 195
    Titles:
      – TitleFull: High CYP2C19 phenotypic variability in gastrointestinal cancer patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Burns KE
      – PersonEntity:
          Name:
            NameFull: Lo WY
      – PersonEntity:
          Name:
            NameFull: Findlay MP
      – PersonEntity:
          Name:
            NameFull: Sharples K
      – PersonEntity:
          Name:
            NameFull: Laking G
      – PersonEntity:
          Name:
            NameFull: Helsby NA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2016 Jan
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0843
          Numbering:
            – Type: volume
              Value: 77
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cancer chemotherapy and pharmacology
              Type: main
ResultId 1